Soluble epoxide hydrolase regulates hematopoietic progenitor cell function via generation of fatty acid diols

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 25, 2012, Pages 9995-10000

  Frömel, Timo ^a   Jungblut, Benno ^b   Hu, Jiong ^a   Trouvain, Caroline ^a   Barbosa Sicard, Eduardo ^a   Popp, Rüdiger ^a   Liebner, Stefan ^a   Dimmeler, Stefanie ^a   Hammock, Bruce D ^c   Fleming, Ingrid ^a  

^a GOETHE UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Beta catenin; Ischemic hindlimb; Linoleic acid

Indexed keywords

EPOXIDE HYDROLASE; FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CELL EXPANSION; CELL FUNCTION; CELL PROLIFERATION; COLONY FORMING UNIT S; DOWN REGULATION; HEMATOPOIETIC STEM CELL; HINDLIMB; LIMB ISCHEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; STEM CELL MOBILIZATION; VASCULAR SURGERY; VEIN; WNT SIGNALING PATHWAY; ZEBRA FISH;

ANIMALS; EPOXIDE HYDROLASES; FATTY ACIDS; GENE KNOCKDOWN TECHNIQUES; HEMATOPOIETIC STEM CELLS; MICE; MICE, INBRED C57BL; ZEBRAFISH;

EID: 84862550071     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1206493109     Document Type: Article

References (38)

1. Konkel A, Schunck WH (2011) Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids. Biochim Biophys Acta 1814:210-222.
2. Campbell WB, Gebremedhin D, Pratt PF, Harder DR (1996) Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 78: 415-423.
3. Fisslthaler B, et al. (1999) Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 401:493-497.
4. Deng Y, et al. (2011) Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice. FASEB J 25:703-713.
5. Fleming I (2011) The cytochrome P450 pathway in angiogenesis and endothelial cell biology. Cancer Metastasis Rev 30:541-555.
6. Goldstone JV, et al. (2010) Identification and developmental expression of the full complement of Cytochrome P450 genes in Zebrafish. BMC Genomics 11:643.
7. Arand M, Cronin A, Oesch F, Mowbray SL, Jones TA (2003) The telltale structures of epoxide hydrolases. Drug Metab Rev 35:365-383.
8. Murayama E, et al. (2006) Tracing hematopoietic precursor migration to successive hematopoietic organs during zebrafish development. Immunity 25:963-975.
9. North TE, et al. (2007) Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 447:1007-1011.
10. Cronin A, et al. (2003) The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase. Proc Natl Acad Sci USA 100:1552-1557.
11. Newman JW, Morisseau C, Harris TR, Hammock BD (2003) The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity. Proc Natl Acad Sci USA 100:1558-1563.
12. Hwang SH, Tsai HJ, Liu JY, Morisseau C, Hammock BD (2007) Orally bioavailable potent soluble epoxide hydrolase inhibitors. J Med Chem 50:3825-3840.
13. Cerdan C, Bhatia M (2010) Novel roles for Notch, Wnt and Hedgehog in hematopoesis derived from human pluripotent stem cells. Int J Dev Biol 54:955-963.
14. DasGupta R, Fuchs E (1999) Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation. Development 126:4557-4568.
15. Wiley DM, et al. (2011) Distinct signalling pathways regulate sprouting angiogenesis from the dorsal aorta and the axial vein. Nat Cell Biol 13:686-692.
16. Webler AC, et al. (2008) Cytochrome P450 2C9-induced angiogenesis is dependent on EphB4. Arterioscler Thromb Vasc Biol 28:1123-1129.
17. Chen AT, Zon LI (2009) Zebrafish blood stem cells. J Cell Biochem 108:35-42.
18. Kissa K, Herbomel P (2010) Blood stem cells emerge from aortic endothelium by a novel type of cell transition. Nature 464:112-115.
19. Bertrand JY, et al. (2010) Haematopoietic stem cells derive directly from aortic endothelium during development. Nature 464:108-111.
20. Burns CE, Zon LI (2006) Homing sweet homing: Odyssey of hematopoietic stem cells. Immunity 25:859-862.
21. Moghaddam MF, et al. (1997) Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase. Nat Med 3:562-566.
22. Thompson DA, Hammock BD (2007) Dihydroxyoctadecamonoenoate esters inhibit the neutrophil respiratory burst. J Biosci 32:279-291.
23. Ramachandran R, Zhao XF, Goldman D (2011) Ascl1a/Dkk/β-catenin signaling pathway is necessary and glycogen synthase kinase-3β inhibition is sufficient for zebrafish retina regeneration. Proc Natl Acad Sci USA 108:15858-15863.
24. 2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell 136:1136-1147.
25. Chen Y, Hu Y, Zhang H, Peng C, Li S (2009) Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia. Nat Genet 41:783-792.
26. Kinder M, et al. (2010) Hematopoietic stem cell function requires 12/15-lipoxygenase-dependent fatty acid metabolism. Blood 115:5012-5022.
27. Seubert JM, et al. (2006) Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function. Circ Res 99:442-450.
28. Tongers J, Roncalli JG, Losordo DW (2010) Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation. Microvasc Res 79:200-206.
29. Wang Y, et al. (2005) Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways. J Pharmacol Exp Ther 314:522-532.
30. Imig JD, Hammock BD (2009) Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat Rev Drug Discov 8:794-805.
31. Smith KR, et al. (2005) Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor. Proc Natl Acad Sci USA 102:2186-2191.
32. Manhiani M, et al. (2009) Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension. Am J Physiol Renal Physiol 297:F740-F748.
33. Zhang LN, et al. (2009) Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation, and dyslipidemia. Arterioscler Thromb Vasc Biol 29:1265-1270.
34. Revermann M, et al. (2010) Soluble epoxide hydrolase deficiency attenuates neointima formation in the femoral cuff model of hyperlipidemic mice. Arterioscler Thromb Vasc Biol 30:909-914.
35. Sinal CJ, et al. (2000) Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation. J Biol Chem 275:40504-40510.
36. Keserü B, et al. (2010) Hypoxia-induced pulmonary hypertension: Comparison of soluble epoxide hydrolase deletion vs. inhibition. Cardiovasc Res 85:232-240.
37. Zhu H, et al. (2005) Regulation of the lmo2 promoter during hematopoietic and vascular development in zebrafish. Dev Biol 281:256-269.
38. Jin SW, Beis D, Mitchell T, Chen JN, Stainier DY (2005) Cellular and molecular analyses of vascular tube and lumen formation in zebrafish. Development 132:5199-5209.